WallStSmart

International Money Express Inc (IMXI)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

International Money Express Inc generates 135% more annual revenue ($607.78M vs $258.90M). IMXI leads profitability with a 5.4% profit margin vs -15.5%. IMXI earns a higher WallStSmart Score of 52/100 (C-).

IMXI

Buy

52

out of 100

Grade: C-

Growth: 2.0Profit: 6.5Value: 6.7Quality: 6.5
Piotroski: 4/9Altman Z: 2.39

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

IMXIUndervalued (+83.4%)

Margin of Safety

+83.4%

Fair Value

$93.37

Current Price

$15.94

$77.43 discount

UndervaluedFair: $93.37Overvalued
ZEPPUndervalued (+48.8%)

Margin of Safety

+48.8%

Fair Value

$46.82

Current Price

$18.43

$28.39 discount

UndervaluedFair: $46.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

IMXI3 strengths · Avg: 8.3/10
Return on EquityProfitability
22.1%9/10

Every $100 of equity generates 22 in profit

P/E RatioValuation
14.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

IMXI4 concerns · Avg: 2.8/10
Market CapQuality
$480.38M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
5.4%3/10

5.4% margin — thin

Debt/EquityHealth
1.213/10

Elevated debt levels

PEG RatioValuation
2.742/10

Expensive relative to growth rate

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : IMXI

The strongest argument for IMXI centers on Return on Equity, P/E Ratio, Price/Book.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : IMXI

The primary concerns for IMXI are Market Cap, Profit Margin, Debt/Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

IMXI profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

IMXI scores higher overall (52/100 vs 41/100). ZEPP offers better value entry with a 48.8% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

International Money Express Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

International Money Express, Inc., through its subsidiary, is a money transfer service company in the United States, Latin America, Mexico, Africa, Central America, South America, and the Caribbean. The company is headquartered in Miami, Florida.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?